Koyfin Home > Directory > Health Care > Boston Scientific Corp

Boston Scientific Corp Price Chart BSX

Historical daily share price chart and data for Boston Scientific Corp since 1992 adjusted for splits and dividends. The latest closing price for Boston Scientific Corp as of November 25, 2020 is $33.55.
  • In 2020 the stock opened at $45.50 and closed at $33.55 for a loss of -36% YTD.
  • In 2019 the stock opened at $34.65 and closed at $45.22 for a gain of 23%.
  • In 2018 the stock opened at $24.94 and closed at $35.34 for a gain of 29%.
  • In 2017 the stock opened at $21.72 and closed at $24.79 for a gain of 12%.
View Chart On Koyfin

Boston Scientific Corp Summary

Stock Symbol: BSX

Boston Scientific Corp Company Info

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
1296.53 %
30D Volatility
Hedge Fund Held
2.77 %

Last 10 Days of BSX Prices